0.3962
Co Diagnostics Inc stock is traded at $0.3962, with a volume of 1.33M.
It is up +0.66% in the last 24 hours and up +4.54% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.3936
Open:
$0.39
24h Volume:
1.33M
Relative Volume:
0.05
Market Cap:
$15.26M
Revenue:
$7.11M
Net Income/Loss:
$-41.28M
P/E Ratio:
-0.2871
EPS:
-1.38
Net Cash Flow:
$-26.84M
1W Performance:
+1.05%
1M Performance:
+4.54%
6M Performance:
+15.98%
1Y Performance:
-66.14%
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CODX
Co Diagnostics Inc
|
0.3962 | 23.48M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
128.82 | 218.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
104.13 | 149.59B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.34 | 135.77B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
95.81 | 118.85B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
85.58 | 48.79B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Predicting Co Diagnostics Inc. trend using moving averagesInsider Buying & Weekly Stock Performance Updates - newser.com
What recovery options are there for Co Diagnostics Inc.2025 Pullback Review & Low Risk Growth Stock Ideas - newser.com
What to Expect from Co-Diagnostics's Earnings - Benzinga
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Gov. Cox, BioUtah recognize Co-Diagnostics (NASDAQ: CODX) after JV in Saudi Arabia - Stock Titan
Why Co Diagnostics Inc. stock remains on buy lists2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Is Co Diagnostics Inc. stock a top momentum playTrade Risk Report & Expert Approved Momentum Trade Ideas - newser.com
Sentiment analysis tools applied to Co Diagnostics Inc.2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Chart overlay techniques for tracking Co Diagnostics Inc.2025 Volume Leaders & Low Drawdown Momentum Trade Ideas - newser.com
What’s next for Co Diagnostics Inc. stock priceQuarterly Profit Review & Target Return Focused Stock Picks - newser.com
Co-Diagnostics (MUN:C97) Price Target Decreased by 32.24% to 1.76 - Nasdaq
How Co Diagnostics Inc. stock compares to industry benchmarksQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
MSN Money - MSN
Co-Diagnostics explores strategic options for Indian joint venture By Investing.com - Investing.com Australia
How sentiment analysis helps forecast Co Diagnostics Inc.Portfolio Profit Report & AI Enhanced Trading Alerts - newser.com
Co-Diagnostics engages Maxim Group for SPAC transaction for Indian JV - Medical Buyer
Ambalal Sarabhai Enterprises' Joint Venture CoSara Diagnostics Explores SPAC Merger - scanx.trade
Developing predictive dashboards with Co Diagnostics Inc. dataJuly 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Is Co Diagnostics Inc. stock supported by strong fundamentals2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com
Co-Diagnostics explores strategic options for Indian joint venture - Investing.com India
Will Co Diagnostics Inc. stock benefit from AI adoptionTrend Reversal & Daily Technical Forecast Reports - newser.com
Co Diagnostics Inc. recovery potential after sell offJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Transcript : Co-Diagnostics, Inc.Special Call - MarketScreener
Co Diagnostics Inc. stock retracement – recovery analysisWeekly Stock Summary & Expert Verified Movement Alerts - newser.com
Is Co Diagnostics Inc. building a consolidation base2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
What is the fair value of Co Diagnostics Inc. stock nowRate Cut & AI Enhanced Trading Signals - newser.com
Co-Diagnostics engages Maxim Group to pursue SPAC transaction for its Indian joint venture, CoSara Diagnostics - MarketScreener
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd – Company AnnouncementFT.com - Financial Times
Day 6 of Loss Streak for Co-Diagnostics Stock with -70% Return (vs. -49% YTD) [11/4/2025] - Trefis
Why Co Diagnostics Inc. stock could rally in 2025Weekly Investment Recap & Fast Moving Market Watchlists - newser.com
Is Co Diagnostics Inc. stock attractive after correctionInsider Selling & Reliable Breakout Stock Forecasts - newser.com
Will Co Diagnostics Inc. stock remain a Wall Street favoriteWeekly Trend Summary & AI Based Trade Execution Alerts - newser.com
What margin trends mean for Co Diagnostics Inc. stockJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Analyzing drawdowns of Co Diagnostics Inc. with statistical toolsJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
AI Breakthrough in Biotech: Co-Diagnostics Unveils Primer AI, Revolutionizing Diagnostics and Disease Prediction - Markets Financial Content
Co-Diagnostics, Inc. to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx Primer AI Platform - MarketScreener
What technical models suggest about Co Diagnostics Inc.’s comebackJuly 2025 Decliners & Daily Entry Point Alerts - newser.com
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):